Ubiquitylation of MYC couples transcription elongation with double-strand break repair at active promoters.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
18 02 2021
Historique:
received: 02 05 2020
revised: 14 10 2020
accepted: 16 12 2020
pubmed: 17 1 2021
medline: 3 3 2021
entrez: 16 1 2021
Statut: ppublish

Résumé

The MYC oncoprotein globally affects the function of RNA polymerase II (RNAPII). The ability of MYC to promote transcription elongation depends on its ubiquitylation. Here, we show that MYC and PAF1c (polymerase II-associated factor 1 complex) interact directly and mutually enhance each other's association with active promoters. PAF1c is rapidly transferred from MYC onto RNAPII. This transfer is driven by the HUWE1 ubiquitin ligase and is required for MYC-dependent transcription elongation. MYC and HUWE1 promote histone H2B ubiquitylation, which alters chromatin structure both for transcription elongation and double-strand break repair. Consistently, MYC suppresses double-strand break accumulation in active genes in a strictly PAF1c-dependent manner. Depletion of PAF1c causes transcription-dependent accumulation of double-strand breaks, despite widespread repair-associated DNA synthesis. Our data show that the transfer of PAF1c from MYC onto RNAPII efficiently couples transcription elongation with double-strand break repair to maintain the genomic integrity of MYC-driven tumor cells.

Identifiants

pubmed: 33453168
pii: S1097-2765(20)30956-4
doi: 10.1016/j.molcel.2020.12.035
pmc: PMC7611325
mid: EMS129538
pii:
doi:

Substances chimiques

Histones 0
MYC protein, human 0
Proto-Oncogene Proteins c-myc 0
Tumor Suppressor Proteins 0
HUWE1 protein, human EC 2.3.2.26
Ubiquitin-Protein Ligases EC 2.3.2.27
RNA Polymerase II EC 2.7.7.-
ATPases Associated with Diverse Cellular Activities EC 3.6.4.-
PEX6 protein, human EC 3.6.4.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

830-844.e13

Subventions

Organisme : European Research Council
ID : 669771
Pays : International

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Genome Res. 2012 May;22(5):837-49
pubmed: 22391556
Nature. 2014 Jul 24;511(7510):488-492
pubmed: 25043028
Science. 2014 Mar 28;343(6178):1470-5
pubmed: 24675954
Nat Rev Cancer. 2015 Oct;15(10):593-607
pubmed: 26383138
Nature. 2018 Aug;560(7720):601-606
pubmed: 30135580
Mol Cell. 2019 May 16;74(4):674-687.e11
pubmed: 30928206
Cell. 2012 Sep 28;151(1):68-79
pubmed: 23021216
Genome Biol. 2014;15(10):482
pubmed: 25287278
Nat Rev Mol Cell Biol. 2020 May;21(5):255-267
pubmed: 32071436
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1148-E1157
pubmed: 28137882
Antimicrob Agents Chemother. 2015 Apr;59(4):2062-71
pubmed: 25624324
Genome Res. 2014 Oct;24(10):1572-83
pubmed: 25049226
Nature. 2019 Mar;567(7749):545-549
pubmed: 30894746
Cell. 2001 Aug 10;106(3):297-307
pubmed: 11509179
Mol Cell. 2019 Jul 25;75(2):267-283.e12
pubmed: 31202576
EMBO Rep. 2019 Sep;20(9):e47987
pubmed: 31334602
Nature. 2014 Apr 10;508(7495):263-8
pubmed: 24590075
Mol Cell. 2018 Oct 18;72(2):250-262.e6
pubmed: 30270107
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Cell. 2010 Apr 30;141(3):432-45
pubmed: 20434984
Mol Cell. 2016 May 5;62(3):409-421
pubmed: 27153538
Cell. 2015 Jun 18;161(7):1592-605
pubmed: 26052046
Cell. 2006 Aug 11;126(3):529-42
pubmed: 16901786
Nat Biotechnol. 2010 Aug;28(8):868-73
pubmed: 20639865
Cell. 2016 Apr 7;165(2):357-71
pubmed: 27058666
Mol Cell. 2016 Jan 7;61(1):54-67
pubmed: 26687678
Cell. 2011 Sep 30;147(1):107-19
pubmed: 21962511
Nat Struct Mol Biol. 2016 May;23(5):434-40
pubmed: 27043296
Cell. 2006 Apr 21;125(2):327-41
pubmed: 16630820
BMC Genomics. 2014 Apr 15;15:284
pubmed: 24735413
J Proteome Res. 2012 Jun 1;11(6):3487-97
pubmed: 22537090
Nat Commun. 2015 Dec 16;6:10191
pubmed: 26671524
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Cancer Res. 2020 Apr 1;80(7):1414-1427
pubmed: 32029551
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2561-2570
pubmed: 30692263
Mol Cell. 2018 Dec 6;72(5):836-848.e7
pubmed: 30415952
Cell. 2011 Sep 30;147(1):95-106
pubmed: 21962510
Cell Rep. 2013 Dec 26;5(6):1704-13
pubmed: 24332856
EMBO Rep. 2018 Apr;19(4):
pubmed: 29467282
Nat Struct Mol Biol. 2019 Jan;26(1):67-77
pubmed: 30598550
Cell. 2009 May 1;137(3):459-71
pubmed: 19410543
Mol Cell. 2011 Oct 21;44(2):325-40
pubmed: 21906983
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Nat Struct Mol Biol. 2013 Mar;20(3):396-403
pubmed: 23416947
J Cell Sci. 2014 Feb 15;127(Pt 4):763-72
pubmed: 24357716
Cell. 2012 Sep 28;151(1):56-67
pubmed: 23021215
Nature. 2014 Aug 28;512(7515):449-52
pubmed: 25164756
Mol Cell Biol. 2004 Jan;24(2):787-95
pubmed: 14701750
Cell. 2012 Aug 17;150(4):697-709
pubmed: 22884692
Cold Spring Harb Perspect Med. 2014 Jun 02;4(6):
pubmed: 24890832
Mol Cell. 2011 Mar 4;41(5):529-42
pubmed: 21362549
Cell Rep. 2017 Dec 19;21(12):3483-3497
pubmed: 29262328
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Genes Dev. 2013 Mar 1;27(5):504-13
pubmed: 23475959
Cell. 2012 Mar 30;149(1):22-35
pubmed: 22464321
Nat Chem Biol. 2018 Feb;14(2):163-170
pubmed: 29251720
Nat Methods. 2012 Feb 28;9(3):215-6
pubmed: 22373907
Nat Commun. 2020 Apr 14;11(1):1827
pubmed: 32286286
Genes Dev. 2016 Feb 1;30(3):337-54
pubmed: 26798134
Nature. 2014 Jul 24;511(7510):483-7
pubmed: 25043018
Mol Cell. 2003 May;11(5):1177-88
pubmed: 12769843
Elife. 2016 Jul 27;5:
pubmed: 27460974
Mol Cell. 2011 Mar 4;41(5):515-28
pubmed: 21362548
Sci Rep. 2019 Jun 27;9(1):9354
pubmed: 31249361
Nature. 2018 Aug;560(7720):607-612
pubmed: 30135578
EMBO Rep. 2003 Jun;4(6):575-80
pubmed: 12776177
Nat Cell Biol. 2006 Jan;8(1):91-9
pubmed: 16341205
Cell. 2010 Oct 15;143(2):313-24
pubmed: 20946988
Genome Res. 2017 Mar;27(3):491-499
pubmed: 28100584
Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):3734-9
pubmed: 25775507
Nat Commun. 2017 May 12;8:15058
pubmed: 28497783
Mol Cell Biol. 2014 Jun;34(11):2062-74
pubmed: 24687851
Cell. 2015 Jan 29;160(3):367-80
pubmed: 25619691
J Biol Chem. 2020 Mar 20;295(12):3990-4000
pubmed: 32029477
Genes Dev. 2014 Aug 15;28(16):1800-14
pubmed: 25128497
Nat Cell Biol. 2007 Jul;9(7):765-74
pubmed: 17558397
Nat Commun. 2014 Aug 18;5:4632
pubmed: 25130259
EMBO Mol Med. 2014 Sep 24;6(12):1525-41
pubmed: 25253726
Science. 2006 Jun 23;312(5781):1798-802
pubmed: 16794079
Nat Chem Biol. 2013 Sep;9(9):548-56
pubmed: 23892893
Cell. 2005 Nov 4;123(3):409-21
pubmed: 16269333
Trends Biochem Sci. 2018 May;43(5):327-341
pubmed: 29699641
Nature. 2019 Sep;573(7772):45-54
pubmed: 31462772
Mol Cell. 2003 May;11(5):1189-200
pubmed: 12769844
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Nature. 2015 Dec 17;528(7582):422-6
pubmed: 26649820
Cell. 2017 Aug 10;170(4):774-786.e19
pubmed: 28802045
J Cell Biol. 2012 Dec 24;199(7):1067-81
pubmed: 23266955
Mol Cell. 2020 Apr 16;78(2):261-274.e5
pubmed: 32155413
Trends Biochem Sci. 2017 Oct;42(10):788-798
pubmed: 28870425
Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9224-E9232
pubmed: 29078288
Mol Cell. 2016 Nov 17;64(4):815-825
pubmed: 27840029
Sci Transl Med. 2019 Mar 20;11(484):
pubmed: 30894502
Mol Cell Proteomics. 2012 Mar;11(3):O111.013698
pubmed: 22159718
Cell Rep. 2014 Nov 6;9(3):1163-70
pubmed: 25437568
Nat Rev Mol Cell Biol. 2019 Dec;20(12):766-784
pubmed: 31558824
Genome Res. 2017 Oct;27(10):1658-1664
pubmed: 28904013
Science. 2018 May 18;360(6390):800-805
pubmed: 29622725

Auteurs

Theresa Endres (T)

Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97074 Würzburg, Germany.

Daniel Solvie (D)

Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97074 Würzburg, Germany.

Jan B Heidelberger (JB)

Institute of Molecular Biology (IMB), Ackermannweg 4, 55128 Mainz, Germany.

Valentina Andrioletti (V)

Internal Medicine VIII-Clinical Tumor Biology, University of Tübingen, Otfried-Müller-Straße 14, 72076 Tübingen, Germany.

Apoorva Baluapuri (A)

Cancer Systems Biology Group, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97074 Würzburg, Germany.

Carsten P Ade (CP)

Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97074 Würzburg, Germany.

Matthias Muhar (M)

Research Institute of Molecular Pathology, Campus Vienna Biocenter 1, 1030 Vienna, Austria.

Ursula Eilers (U)

Core Unit High-Content Microscopy, Biocenter, University of Würzburg, 97074 Würzburg, Germany.

Seychelle M Vos (SM)

Department of Molecular Biology, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany; Massachusetts Institute of Technology, Department of Biology, 31 Ames Street, Cambridge, MA 02139, USA.

Patrick Cramer (P)

Department of Molecular Biology, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany.

Johannes Zuber (J)

Research Institute of Molecular Pathology, Campus Vienna Biocenter 1, 1030 Vienna, Austria.

Petra Beli (P)

Institute of Molecular Biology (IMB), Ackermannweg 4, 55128 Mainz, Germany.

Nikita Popov (N)

Internal Medicine VIII-Clinical Tumor Biology, University of Tübingen, Otfried-Müller-Straße 14, 72076 Tübingen, Germany.

Elmar Wolf (E)

Cancer Systems Biology Group, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97074 Würzburg, Germany.

Peter Gallant (P)

Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97074 Würzburg, Germany.

Martin Eilers (M)

Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, 97074 Würzburg, Germany. Electronic address: martin.eilers@biozentrum.uni-wuerzburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH